News

Transactions Ranged from PIPE Financings, Follow-On Public Offerings to IPOs

02.22.2021

Sheppard Mullin’s Capital Markets team acted as counsel on 14 transactions raising more than $695 million in gross proceeds, all of which closed between February 5-17, 2021.  In all, the team worked on transactions in which they represented three Placement Agents (on five Registered Direct Offerings); four Underwriters (on one IPO and three Follow-On Public Offerings); and five Issuers on Public and Private Offerings (one SPAC IPO, one Follow-On Public Offering, two Registered Direct Offerings, and one PIPE Financing).

The transactions ranged from a $4.276 million PIPE Financing to a $225 million SPAC IPO.  The Sheppard Mullin attorneys involved in the transactions included partners Jeffrey Fessler, Richard Friedman, Stephen Cohen and John Hempill; associates Justin Anslow, Nazia Khan, Alex Yarbrough, Taylor Ashton, Seth Lemings and Yuanmei Liu; attorney Emily Mastoloni; and law clerk Brett Uslaner.

• Represented the Placement Agent in connection with Luokung Technology Corp.’s $100 million registered direct offering of common stock and warrants (February 17)

• Represented the Issuer in connection with Hepion Pharmaceuticals, Inc.’s $88.4 million public offering of common stock (February 16)
• Represented the Underwriter in connection with Alkido Pharma, Inc.’s $75 million bought deal offering of common stock (February 16)

• Represented the Underwriter in connection with Virpax Pharmaceuticals, Inc.’s $18 million Initial Public Offering of common stock (February 16)
• Represented the Issuer in connection with Astrotech Corporation’s $9.248 million registered direct offering (February 8)
• Represented the Placement Agent in connection with Arch Therapeutics, Inc.’s $6.9 million PIPE Financing of common stock and warrants (February 11)

• Represented the Placement Agent in connection with MICT, Inc.’s $60 million registered direct offering of common stock and warrants (February 11)

• Represented the Placement Agent in connection with Luokung Technology Corp.’s $15 million registered direct offering of common stock and warrants (February 11)

• Represented the Issuer (SPAC) in connection with Goal Acquisition Corp.’s $225 million Initial Public Offering of units and listing on Nasdaq (February 10)

• Represented the Issuer in connection with Silo Pharma, Inc.’s $4.276 million PIPE financing of common stock and warrants (February 9)
• Represented the Underwriter in connection with Hancock Jaffe Laboratories, Inc.’s $41.4 million public offering of common stock and warrants (February 9)

• Represented the Underwriter in connection with Ideal Power, Inc.’s $23 million public offering of common stock (February 8)

• Represented the Issuer in connection with Genprex, Inc.’s $25 million registered direct offering (February 8)
• Represented the Placement Agent in connection with Luokung Technology Corp.’s $5 million registered direct offering of common stock and warrants of (February 5)